Bacterial conjunctivitis in children: Antibacterial treatment options in an era of increasing drug resistance

Clinical Pediatrics

Volumn 50, Issue 1, 2011, Pages 7-13

  Pichichero, Michael E ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BACITRACIN; BESIFLOXACIN; CEFIXIME; CIPROFLOXACIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; NEOMYCIN; OFLOXACIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; TRIMETHOPRIM SULFATE; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIOSTASIS; BURNING SENSATION; CHEMOSIS; CHILD; CLASSIFICATION ALGORITHM; CONJUNCTIVITIS; CONTACT DERMATITIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERYTHEMA; EYE ALLERGY; EYE IRRITATION; EYE TOXICITY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PAIN; PHOTOPHOBIA; SENSITIZATION; SIDE EFFECT; STINGING SENSATION;

ACUTE DISEASE; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; CONJUNCTIVITIS, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MACROLIDES; MALE; OPHTHALMIC SOLUTIONS; POLYMYXIN B; PRACTICE GUIDELINES AS TOPIC;

EID: 78650180757     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922810379045     Document Type: Article

References (33)

1. Leibowitz HM The red eye. N Engl J Med. 2000 ; 343: 345-351.
2. Morrow GL, Abbott RL Conjunctivitis. Am Fam Physician. 1998 ; 57: 735-746.
3. Patel PB, Diaz MC, Bennett JE, Attia MW Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007 ; 14: 1-5.
4. Sheikh A., Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract. 2001 ; 51: 473-477. (Pubitemid 32509650)
5. Teoh DL, Reynolds S. Diagnosis and management of pediatric conjunctivitis. Pediatr Emerg Care. 2003 ; 19: 48-55.
6. Bodor FF Conjunctivitis-otitis syndrome. Pediatrics. 1982 ; 69: 695-698.
7. Rose P. Management strategies for acute infective conjunctivitis in primary care: a systematic review. Expert Opin Pharmacother. 2007 ; 8: 1903-1921.
8. Sheikh A., Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis. Br J Gen Pract. 2005: 55: 962-964.
9. Harbarth S., Samore MH Antimicrobial resistance determinants and future control. Emerg Infect Dis. 2005 ; 11: 794-801.
10. Asbell PA, Colby KA, Deng S., et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008 ; 145: 951-958.
11. Asbell PA, Sahm DF, Shaw M., Draghi DC, Brown NP Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008 ; 34: 814-818.
12. Block SL, Hedrick J., Tyler R., et al. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemother. 2000 ; 44: 1650-1654.
13. Sheikh A., Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006 ; 19 (2). CD001211.
14. Bodor FF Systemic antibiotics for the treatment of the conjunctivitis otitis media syndrome. Pediatr Infect Dis J. 1989 ; 8: 287-290.
15. Mah FS New antibiotics for bacterial infections. Ophthalmol Clin North Am. 2003 ; 16: 11-27.
16. Wald ER, Greenberg D., Hoberman A. Short-term oral cefixime therapy for treatment of bacterial conjunctivitis. Pediatr Infect Dis J. 2001 ; 20: 1039-1042.
17. Cavuoto K., Zutshi D., Karp CL, Miller D., Feuer W. Update on bacterial conjunctivitis in South Florida. Ophthalmology. 2008 ; 115: 51-56.
18. Gwon A. ; for the Ofloxacin Study Group. Topical ofloxacin compared with gentamicin in the treatment of ocular infection. Br J Ophthalmol. 1992 ; 76: 714-718.
19. Cagle G., Davis S., Rosenthal A., Smith J. Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. Curr Eye Res. 1981 ; 1: 523-534.
20. Timewell RM, Rosenthal AL, Smith JP, Cagle GD Safety and efficacy of tobramycin and gentamicin in the treatment of external ocular infections of children. J Pediatr Ophthalmol Strabismus. 1983 ; 20: 22-26.
21. Abelson MB, Heller W., Shapiro AM, Si E., Hsu P., Bowman LM ; AzaSite Clinical Study Group. Clinical cure of bacterial conjunctivitis with azithromycin 1%; vehicle-controlled, double-masked clinical trial. Am J Ophthalmol. 2008 ; 145: 959-965.
22. Ohnsman C., Ritterband D., O'Brien T., Girgis D., Kabat A. Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis. Curr Med Res Opin. 2007 ; 23: 2241-2249.
23. Kaliamurthy J., Nelson Jesudasan CA, Parmar P., Kalavathy CM, Thomas PA Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics. Ophthalmic Res. 2005 ; 37: 117-122.
24. Keating GM Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery. Drugs. 2009 ; 69: 1267-1286.
25. Karpecki P., DePaolis M., Hunter JA, et al. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: a multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. Clin Ther. 2009 ; 31: 514-526.
26. McDonald MB, Protzko EE, Brunner LS, et al. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis Ophthalmology. 2009 ; 116: 1615-1623.
27. Comstock TL, Paterno MR, Lynch JA, Usner DW, Pichichero, ME Efficacy and safety of besifloxacin ophthalmic suspension, 0.6% in pediatric patients with bacterial conjunctivitis. Pediatr Drugs. 2010 ; 12: 105-112.
28. Fukuda H., Kishii R., Takei M., Hosaka M. Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae. Antimicrob Agents Chemother. 2001 ; 45: 1649-1653.
29. McDonald MB, Blondeau JM, DeCory HH, et al. Multidrug-resistant strains in clinical trials of besifloxacin in the treatment of bacterial conjunctivitis. Poster presented at: American Academy of Ophthalmology Annual Meeting ; November 8-11, 2008 ; Atlanta, GA.
30. Chou TM, Gigliotti F., Lichtenstein SJ Bacterial conjunctivitis: setting a course for containment and cure. Contemp Pediatr. 2004 ; 21: 2-8.
31. Jacob SE, James WD From road rash to top allergen in a flash: bacitracin. Dermatol Surg. 2004 ; 30 (4 Pt 1). 521-524.
32. Roberts C. Comparison of the ocular comfort of ofloxacin 0.3% ophthalmic solution and lubricant eye drops. Clin Pediatr. 2002 ; 41: 151-154.
33. Granet D., Lichtenstein SJ, Onofrey B., Katz JA An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite. Clin Ophthalmol. 2007 ; 1: 519-525.